Venlafaxine hydrochloride 37.5 mg/1

Venlafaxine hydrochloride 37.5 mg extended-release capsules are used to manage depression and anxiety disorders. This medication is designed for oral use and is manufactured by Macleods Pharmaceuticals Limited.

Venlafaxine hydrochloride is primarily used for the management of major depressive disorder and generalized anxiety disorder. It works by affecting the balance of certain natural substances in the brain. This medication is often prescribed to help alleviate symptoms associated with these conditions, such as persistent sadness, anxiety, and changes in sleep or appetite.

Common effects of Venlafaxine hydrochloride may include drowsiness, dizziness, nausea, and dry mouth. Some users may also experience changes in appetite or weight. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Venlafaxine hydrochloride should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to abruptly stop taking the medication without consulting a healthcare provider. This medication may cause drowsiness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you.

Venlafaxine hydrochloride may interact with other medications, including those that affect serotonin levels, such as SSRIs and SNRIs. It is also important to avoid consuming alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.